Kromek announces its final results for the year ended 30 April 2025
Dr Arnab Basu, CEO of Kromek, said: “This year has been pivotal for Kromek, marked by our maiden profit, which exceeded market expectations, and a significant reduction in debt. These achievements were driven by a landmark agreement with Siemens Healthineers, showcasing the strength of our Advanced Imaging division. While the CBRN Detection division had a slower start, the second half saw a sharp acceleration in momentum due to contract awards under UK Government frameworks, US federal contracts and a healthy international sales pipeline".